The Effects of Inhaled Nitric Oxide After Fontan Operation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Congenital Heart Defect
Interventions
DRUG

inhaled nitric oxide (iNO)

Inhaled nitric oxide 40ppm for 48 hours followed by a 6-hour wean.

Trial Locations (1)

19803

A. I. duPont Hospital for Children/Nemours Cardiac Center, Wilmington

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Ellen Spurrier

OTHER

NCT00945529 - The Effects of Inhaled Nitric Oxide After Fontan Operation | Biotech Hunter | Biotech Hunter